Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cortes

Showing results (241-250 of 584) with videos related to

Pageof 59
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2013
Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complicationsI I Raad, A M Chaftari, M M Al Shuaibi, et al.
Cancer|May 19, 2012
Impact of numerical variation in FMS-like tyrosine kinase receptor 3 internal tandem duplications on clinical outcome in normal karyotype acute myelogenous leukemiaGautam Borthakur, Hagop Kantarjian, Keyur P Patel, et al.
Leukemia|September 11, 2025
Estimating the burden of chronic stress through allostatic load in patients with chronic myeloid leukemiaMarisol Miranda-Galvis, Kellen C Tjioe, Muhannad Sharara, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 2, 2013
Clofarabine does not negatively impact the outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantationMichael S Mathisen, Hagop Kantarjian, Elias Jabbour, et al.
Haematologica|July 13, 2023
Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II studyJorge E Cortes, Jeff H Lipton, Vamsi Kota, et al.
Cancer Science|May 17, 2008
The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutationTaghi Manshouri, Alfonso Quintás-Cardama, Roberto H Nussenzveig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2014
Reversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategiesWeiguo Zhang, Chen Gao, Marina Konopleva, et al.
Leukemia & Lymphoma|August 3, 2002
Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disordersApostolia M Tsimberidou, Susan M O'Brien, Jorge E Cortes, et al.
Cancer|January 11, 2011
Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemiaGloria N Mattiuzzi, Jorge E Cortes, Deborah A Blamble, et al.
Journal of Cellular and Molecular Medicine|June 11, 2009
Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukaemia cellsPing Shi, Joya Chandra, Xiaoping Sun, et al.
Pageof 59

Showing results (241-250 of 584) with videos related to

Sort By:
Pageof 59
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2013
Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complicationsI I Raad, A M Chaftari, M M Al Shuaibi, et al.
Cancer|May 19, 2012
Impact of numerical variation in FMS-like tyrosine kinase receptor 3 internal tandem duplications on clinical outcome in normal karyotype acute myelogenous leukemiaGautam Borthakur, Hagop Kantarjian, Keyur P Patel, et al.
Leukemia|September 11, 2025
Estimating the burden of chronic stress through allostatic load in patients with chronic myeloid leukemiaMarisol Miranda-Galvis, Kellen C Tjioe, Muhannad Sharara, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 2, 2013
Clofarabine does not negatively impact the outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantationMichael S Mathisen, Hagop Kantarjian, Elias Jabbour, et al.
Haematologica|July 13, 2023
Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II studyJorge E Cortes, Jeff H Lipton, Vamsi Kota, et al.
Cancer Science|May 17, 2008
The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutationTaghi Manshouri, Alfonso Quintás-Cardama, Roberto H Nussenzveig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2014
Reversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategiesWeiguo Zhang, Chen Gao, Marina Konopleva, et al.
Leukemia & Lymphoma|August 3, 2002
Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disordersApostolia M Tsimberidou, Susan M O'Brien, Jorge E Cortes, et al.
Cancer|January 11, 2011
Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemiaGloria N Mattiuzzi, Jorge E Cortes, Deborah A Blamble, et al.
Journal of Cellular and Molecular Medicine|June 11, 2009
Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukaemia cellsPing Shi, Joya Chandra, Xiaoping Sun, et al.
Pageof 59